{
    "organizations": [],
    "uuid": "68523e45fd80b4f519d87880dbed40297f1df38d",
    "author": "Charley Grant",
    "url": "https://www.wsj.com/articles/no-fda-seal-of-approval-for-these-big-biotechs-1526577113",
    "ord_in_thread": 0,
    "title": "No FDA Seal of Approval for These Big Biotechs",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Investors got another reminder that profits at large biotech companies are fragile.\nThe Food and Drug Administration published a list of companies Thursday that it says employ “gaming tactics” to delay generic competition for branded drugs.\nThe FDA’s list of 52 drugs includes blockbuster treatments for serious diseases. High-profile examples... To Read the Full Story Subscribe Sign In",
    "published": "2018-05-17T21:11:00.000+03:00",
    "crawled": "2018-05-17T22:52:39.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "investor",
        "got",
        "another",
        "reminder",
        "profit",
        "large",
        "biotech",
        "company",
        "fragile",
        "food",
        "drug",
        "administration",
        "published",
        "list",
        "company",
        "thursday",
        "say",
        "employ",
        "gaming",
        "tactic",
        "delay",
        "generic",
        "competition",
        "branded",
        "drug",
        "fda",
        "list",
        "drug",
        "includes",
        "blockbuster",
        "treatment",
        "serious",
        "disease",
        "example",
        "read",
        "full",
        "story",
        "subscribe",
        "sign"
    ]
}